Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Oncol
2022 Oct 01;1619:3554-3567. doi: 10.1002/1878-0261.13301.
Show Gene links
Show Anatomy links
Disruption of tp53 leads to cutaneous nevus and melanoma formation in Xenopus tropicalis.
Ran R
,
Li L
,
Shi Z
,
Liu G
,
Jiang H
,
Fang L
,
Xu T
,
Huang J
,
Chen W
,
Chen Y
.
???displayArticle.abstract???
In humans, germline TP53 mutations predispose carriers to a wide spectrum of cancers, which is known as Li-Fraumeni syndrome (LFS). To date, the association of melanomas with LFS remains unestablished. No melanomas have been reported in any P53-modified mouse models either. In this study, we show that targeted disruption of P53 at the DNA-binding domain in Xenopus tropicalis recapitulates LFS, with the formation of soft-tissue sarcomas and pancreatic ductal adenocarcinoma. Interestingly, 19% of the 14-month-old tp53Δ7/Δ7 homozygotes and 18% of tp53+/Δ7 heterozygotes spontaneously developed small nevi and non-invasive melanomas. Large invasive melanomas were also observed in other older homozygous mutants, with about 7.9% penetrance. Our data suggest that more dermatologic investigation of LFS patients should be able to settle the association of melanoma with LFS in epidemiology. Our model is also valuable for further investigation of the molecular mechanism underlying melanoma progression upon germline alteration of the tp53 locus.
ZDSYS20140509142721429 Shenzhen Key Laboratory of Cell Microenvironment, JCYJ20210324120205015 Shenzhen Science and Technology Program, 2017B030301018 Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research
Anbarasan,
The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases.
2019, Pubmed
Anbarasan,
The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases.
2019,
Pubmed
Baker,
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
1989,
Pubmed
Berghmans,
tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors.
2005,
Pubmed
Caramel,
A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.
2013,
Pubmed
Donehower,
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
1992,
Pubmed
Dudgeon,
The evolution of thymic lymphomas in p53 knockout mice.
2014,
Pubmed
Frebourg,
Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes.
2020,
Pubmed
Gelmi,
MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance.
2022,
Pubmed
Guha,
Inherited TP53 Mutations and the Li-Fraumeni Syndrome.
2017,
Pubmed
Guo,
Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis.
2014,
Pubmed
,
Xenbase
Haeussler,
Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR.
2016,
Pubmed
Harvey,
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
1993,
Pubmed
Harvey,
Genetic background alters the spectrum of tumors that develop in p53-deficient mice.
1993,
Pubmed
Haslam,
From frog integument to human skin: dermatological perspectives from frog skin biology.
2014,
Pubmed
Hessler,
Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities.
2020,
Pubmed
Ignatius,
tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish.
2018,
Pubmed
Jacks,
Tumor spectrum analysis in p53-mutant mice.
1994,
Pubmed
Joruiz,
p53 Isoforms: Key Regulators of the Cell Fate Decision.
2016,
Pubmed
Kaufman,
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation.
2016,
Pubmed
Kuperwasser,
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.
2000,
Pubmed
Le Loarer,
Advances in the classification of round cell sarcomas.
2022,
Pubmed
Liu,
High metastatic potential in mice inheriting a targeted p53 missense mutation.
2000,
Pubmed
Liu,
Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice.
2004,
Pubmed
McGill,
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
2002,
Pubmed
Mehta,
Adaptive homeostasis and the p53 isoform network.
2021,
Pubmed
Miller,
Melanoma.
2006,
Pubmed
Naert,
RBL1 (p107) functions as tumor suppressor in glioblastoma and small-cell pancreatic neuroendocrine carcinoma in Xenopus tropicalis.
2020,
Pubmed
,
Xenbase
Neesse,
Stromal biology and therapy in pancreatic cancer: a changing paradigm.
2015,
Pubmed
Norimura,
p53-dependent apoptosis suppresses radiation-induced teratogenesis.
1996,
Pubmed
Olive,
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
2004,
Pubmed
Parant,
Genetic modeling of Li-Fraumeni syndrome in zebrafish.
2010,
Pubmed
Sabapathy,
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others.
2018,
Pubmed
Sandru,
Melanoma in patients with Li-Fraumeni syndrome (Review).
2022,
Pubmed
Sensi,
Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.
2011,
Pubmed
Shi,
Modeling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 system.
2019,
Pubmed
,
Xenbase
Shive,
BRCA2 and TP53 collaborate in tumorigenesis in zebrafish.
2014,
Pubmed
Stancheva,
Loss of the maintenance methyltransferase, xDnmt1, induces apoptosis in Xenopus embryos.
2001,
Pubmed
,
Xenbase
Wagner,
Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy.
1997,
Pubmed
Xiong,
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.
2014,
Pubmed
Zuasti,
The melanogenic system of Xenopus laevis.
1998,
Pubmed
,
Xenbase
